Engin Gul

6PUBLICATIONS
24CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 16, 2026
Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

|Sep 11, 2024
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.

Arleigh McCurdy, Donna Reece, Martha L Louzada

|Jan 04, 2024
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial.

Suzanne Trudel, Arleigh McCurdy, Martha L Louzada

|Dec 08, 2023
Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database.

A Visram, A De La Torre, D White

|Sep 05, 2023
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database.

Julie Côté, Richard LeBlanc, Hira Mian

|Aug 13, 2023
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.

Richard LeBlanc, Hira Mian, Donna Reece

Pageof 1

Frequent Collaborators

4 joint publications

Donna Reece

3 joint publications

Arleigh McCurdy

3 joint publications

Hira Mian

2 joint publications

Suzanne Trudel